THERAPEUTIC AND ANTISENSE OLIGONUCLEOTIDS, CONJUGATE, PHARMACEUTICALLY ACCEPTABLE SALT, PHARMACEUTICAL COMPOSITION, IN VITRO OR IN VIVO METHOD TO MODULATE THE EXPRESSION OF TMEM106B, METHOD FOR TREATING OR PREVENTING ILLNESS, USE
The present invention relates to oligonucleotides that are complementary to and modulate the expression of TMEM106B. The present invention further relates to oligonucleotide conjugates and pharmaceutical compositions and methods for treating neurological disorders using the oligonucleotide.